ISOCIPRALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

isoprenaline hydrochloride, Quantity: 1 mg

から入手可能:

Cipla Australia Pty Ltd

医薬品形態:

Injection, solution

構図:

Excipient Ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections

投与経路:

Intracardial, Subcutaneous, Intramuscular, Intravenous Infusion, Intravenous Bolus

パッケージ内のユニット:

10 x 5 mL Ampoules

処方タイプ:

(S4) Prescription Only Medicine

適応症:

ISOCIPRALINE is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 Contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 Contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 Special warnings and precautions for use).

製品概要:

Visual Identification: Clear colourless to practically colourless solution and no visible particulates; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Registered

承認日:

2022-03-24